1. A pill for HCV – myth or foreseeable future?. Issue 1 (2nd September 2013) Authors: Jaroszewicz, Jerzy; Flisiak, Robert; Dusheiko, Geoffrey Journal: Liver international Issue: Volume 34:Issue 1(2014) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Issue 4 (10th August 2015) Authors: Pawlotsky, Jean‐Michel; Flisiak, Robert; Sarin, Shiv K.; Rasenack, Jens; Piratvisuth, Teerha; Chuang, Wan‐Long; Peng, Cheng‐Yuan; Foster, Graham R.; Shah, Samir; Wedemeyer, Heiner; Hézode, Christophe; Zhang, Wei; Wong, Kelly A.; Li, Bin; Avila, Claudio; Naoumov, Nikolai V.; on behalf of the VITAL... Journal: Hepatology Issue: Volume 62:Issue 4(2015:Oct.) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism. Issue 2 (1st June 2015) Authors: Rogalska‐Taranta, Magdalena; Markova, Antoaneta A.; Taranta, Andrzej; Lunemann, Sebastian; Schlaphoff, Verena; Flisiak, Robert; Manns, Michael P.; Cornberg, Markus; Kraft, Anke R. M.; Wedemeyer, Heiner Journal: Journal of leukocyte biology Issue: Volume 98:Issue 2(2015) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism. Issue 2 (1st June 2015) Authors: Rogalska-Taranta, Magdalena; Markova, Antoaneta A; Taranta, Andrzej; Lunemann, Sebastian; Schlaphoff, Verena; Flisiak, Robert; Manns, Michael P; Cornberg, Markus; Kraft, Anke R M; Wedemeyer, Heiner Journal: Journal of leukocyte biology Issue: Volume 98:Issue 2(2015) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history*. (4th March 2019) Authors: Rogalski, Pawel; Rogalska-Plonska, Magdalena; Wroblewski, Eugeniusz; Kostecka-Roslen, Ines; Dabrowska, Milena; Swidnicka-Siergiejko, Agnieszka; Wasielica-Berger, Justyna; Cydzik, Mariusz; Hirnle, Tomasz; Dobrzycki, Slawomir; Flisiak, Robert; Dabrowski, Andrzej Journal: Scandinavian journal of gastroenterology Issue: Volume 54:Number 3(2019) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Issue 2 (June 2016) Authors: Ferenci, Peter; Caruntu, Florin; Lengyel, Gabriella; Messinger, Diethelm; Bakalos, Georgios; Flisiak, Robert Journal: Infectious diseases and therapy Issue: Volume 5:Issue 2(2016) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correction: Quantitative Measurement of HCV Core Antigen for Management of Interferon-Free Therapy in HCV-Infected Patients. Issue 4 (May 2018) Authors: Łucejko, Mariusz; Flisiak, Robert Journal: Antiviral therapy Issue: Volume 23:Issue 4(2018) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis. (September 2015) Authors: Jaroszewicz, Jerzy; Flisiak-Jackiewicz, Marta; Lebensztejn, Dariusz; Flisiak, Robert Journal: Expert opinion on investigational drugs Issue: Volume 24:Number 9(2015:Sep.) Page Start: 1229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Early oral antiviral use in patients hospitalised with COVID-19. Issue 12 (December 2022) Authors: Zarębska-Michaluk, Dorota; Flisiak, Robert Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis. Issue 38 (September 2015) Authors: Janczewska, Ewa; Flisiak, Robert; Zarebska-Michaluk, Dorota; Kozielewicz, Dorota; Berak, Hanna; Dobracka, Beata; Librant-Suska, Marta; Lojewski, Wladyslaw; Jurczyk, Krzysztof; Musialik, Joanna; Postawa-Klosińska, Barbara; Wroblewski, Jacek; Augustyniak, Krystyna; Dudziak, Marek; Olszok, Iwona; Ru... Journal: Medicine Issue: Volume 94:Issue 38(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗